It has been shown that some dietary supplementation resulted in the enrichment of microbiota-derived inosine or exogenous inosine treatment could activate PPARγ signaling in human colonic epithelial cells and protect against DSS-induced colitis through the improvement of adenosine 2A receptor (A2AR)/PPARγ-dependent mucosal barrier functions. This evidence concerns the gene PPARG and colitis.